BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 25883322)

  • 1. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins.
    Wang ET; Ward AJ; Cherone JM; Giudice J; Wang TT; Treacy DJ; Lambert NJ; Freese P; Saxena T; Cooper TA; Burge CB
    Genome Res; 2015 Jun; 25(6):858-71. PubMed ID: 25883322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
    Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
    Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of alternative untranslated regions within the mRNA of the CELF1 splicing factor affects its expression.
    Kajdasz A; Niewiadomska D; Sekrecki M; Sobczak K
    Sci Rep; 2022 Jan; 12(1):190. PubMed ID: 34996980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Targets of CUG-BP, Elav-Like Family Member 1 (CELF1) Regulation in Embryonic Heart Muscle.
    Blech-Hermoni Y; Dasgupta T; Coram RJ; Ladd AN
    PLoS One; 2016; 11(2):e0149061. PubMed ID: 26866591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.
    Ladd AN; Charlet N; Cooper TA
    Mol Cell Biol; 2001 Feb; 21(4):1285-96. PubMed ID: 11158314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.
    Wang ET; Cody NA; Jog S; Biancolella M; Wang TT; Treacy DJ; Luo S; Schroth GP; Housman DE; Reddy S; Lécuyer E; Burge CB
    Cell; 2012 Aug; 150(4):710-24. PubMed ID: 22901804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
    Pascual M; Vicente M; Monferrer L; Artero R
    Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.
    Kalsotra A; Xiao X; Ward AJ; Castle JC; Johnson JM; Burge CB; Cooper TA
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20333-8. PubMed ID: 19075228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A muscleblind knockout model for myotonic dystrophy.
    Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
    Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
    Nezu Y; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Neuromuscul Disord; 2007 Apr; 17(4):306-12. PubMed ID: 17331722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
    Terenzi F; Ladd AN
    RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes.
    Gazzara MR; Mallory MJ; Roytenberg R; Lindberg JP; Jha A; Lynch KW; Barash Y
    Genome Res; 2017 Aug; 27(8):1360-1370. PubMed ID: 28512194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
    Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
    Kanadia RN; Shin J; Yuan Y; Beattie SG; Wheeler TM; Thornton CA; Swanson MS
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11748-53. PubMed ID: 16864772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nuclear but not cytoplasmic activities of CELF1 protein leads to muscle wasting.
    Cox DC; Guan X; Xia Z; Cooper TA
    Hum Mol Genet; 2020 Jun; 29(10):1729-1744. PubMed ID: 32412585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal cardiac dysfunction and transcriptome changes caused by the absence of Celf1.
    Giudice J; Xia Z; Li W; Cooper TA
    Sci Rep; 2016 Oct; 6():35550. PubMed ID: 27759042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
    Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
    Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1.
    Ohsawa N; Koebis M; Mitsuhashi H; Nishino I; Ishiura S
    Genes Cells; 2015 Feb; 20(2):121-34. PubMed ID: 25403273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
    Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity.
    Peng X; Shen X; Chen X; Liang R; Azares AR; Liu Y
    Biochim Biophys Acta; 2015 Jul; 1852(7):1490-7. PubMed ID: 25887157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.